Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere®) Donald J. DykesMarie Christine BisseryWilliam R. Waud Preclinical Studies Pages: 1 - 11
P-Glycoprotein mediated resistance to 5′-nor-anhydro-vinblastine (Navelbine®) David J. AdamsVincent C. Knick Preclinical Studies Pages: 13 - 21
Preclinical antitumor activity of ethyldeshydroxysparsomycin in combination with cisplatin H. P. HofsD. J. Th. WagenerW. J. De Grip Preclinical Studies Pages: 23 - 32
Hepsulfam distribution in blood, plasma and cerebrospinal fluid of baboons Milton V. MarshallK. Dee CareyJohn G. Kuhn Preclinical Studies Pages: 33 - 36
Binding of a new multidrug resistance modulator, S9788, to human plasma proteins and erythrocytes Saïk UrienPhuc NguyenJean-Paul Tillement Preclinical Studies Pages: 37 - 41
Adenocarcinoma of unknown primary: retrospective analysis of chemosensitivity of 313 freshly explanted tumors in a tumor cloning system Axel -R. HanauskeGary M. ClarkDaniel D. Von Hoff Preclinical Studies Pages: 43 - 49
Stimulation of tumor growthin vitro andin vivo by suramin on the VX2 model Luis H. RamirezMorbize JuliéronJean-Nicolas Munck Brief Report Pages: 51 - 53
Phase I trial of pentosan polysulfate Sandra M. SwainBernard ParkerRobert DeLap Phase I Studies Pages: 55 - 62
A phase I study of sulofenur in refractory pediatric malignant solid tumors Charles B. PrattLaura C. BowmanWilliam H. Meyer Phase I Studies Pages: 63 - 66
Phase II trial and cost analysis of fazarabine in advanced non-small cell carcinoma of the lung: A southwest oncology group study Stephen K. WilliamsonJohn J. CrowleyJohn Wendall Goodwin Phase II Studies Pages: 67 - 71
Phase II study of cisplatin, 5-fluorouracil and interferon-α in recurrent carcinoma of the cervix César Gonzales-de LéonScott M. LippmanJohn J. Kavanagh Phase II Studies Pages: 73 - 76
A phase II trial of Doxorubicin HCl Liposome Injection in patients with advanced pancreatic adenocarcinoma Gary K. SchwartzEphraim S. Casper Phase II Studies Pages: 77 - 82
A phase II trial of piroxantrone in disseminated malignant melanoma J. A. SosmanL. E. FlahertyV. Sondak Phase II Studies Pages: 83 - 87
Experience of the treatment with Sehydrin (Hydrazine Sulfate, HS) in the advanced cancer patients Vladimir A. FilovMichail L. GershanovichBoris A. Ivin Phase II Studies Pages: 89 - 97
Pharmacology, relative bioavailability, and toxicity of three different oral cyclophosphamide preparations in a randomized, cross-over study David J. StewartLee Roy Morgan JrMarion Thibault Bioavailability Study Pages: 99 - 107